ClinicalTrials.gg
Status unknownNCT03347721Updated Mar 21, 2018

Does Lidocaine Gel Decrease Pain Perception in Women Undergoing Diagnostic Flexible Cystoscopy

A Phase 4 interventional study of lidocaine gel and Lubricant Gel in Cystoscopy, Lidocaine and Pain Perception, sponsored by Louisiana State University Health Sciences Center in New Orleans. Status unknown at 1 site in United States. Open to female participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-03-21.

Sponsored by Louisiana State University Health Sciences Center in New Orleans · Phase 4, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2018), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Dec 2016, registered Nov 2017).
Phase
Phase 4
Study type
Interventional
Enrollment
129
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 204 studies testing lidocaine in Pain — 19 open to participants now, 19 under way, 1 of them phase 3. Lidocaine · Pain.

Enrollment
49th of 203
129 · median 66
Started
2016
with 12 others
Phase 4
63 of 204
6 open now
Registered
131st of 204
by date

Among the 204 studies testing lidocaine in Pain, this one is the 49th largest by enrollment of the 203 interventional ones, is one of 13 that started in 2016, is one of 63 in phase 4, and was the 131st registered.

By phase

204 studies; the count open now beside each. This study's row is marked.

No phase79 · 9 open
Phase 4this study63 · 6 open
Phase 322 · 0 open
Phase 217 · 2 open
Phase 2/312 · 1 open
Phase 18 · 0 open
Phase 1/23 · 1 open

By the year they started

First in 2002; this study’s year is marked. 13 started in 2016.

Size and results

Median enrollment 66 across the 203 interventional studies. Of the 157 that completed or were terminated, 66 (42%) have results posted.

Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 204 studies testing lidocaine in Pain, or all of them as a file.
02

Study summary

This study is to determine if there is a clinically meaningful difference in pain perception for women during in-office diagnostic flexible cystoscopy when using lidocaine gel vs plain lubricant. This will be a double blinded randomized control trial.

Read the detailed description

The use of anesthetic lubricant during in-office flexible cystoscopy has been well studied men. Pain during cystoscopy can lead to poor compliance and follow-up. Very few studies challenging the use of anesthetic lubricant during cystoscopy have included women. Those that have, only recruited a small number with insignificant findings. A meta-analysis reviewed four studies looking at the efficacy of lidocaine gel on pain relief during flexible cystoscopy in men. Four hundred and eleven men underwent flexible cystoscopy with and without the use of lidocaine gel and those who received anesthetic gel were 1.7 times more likely not to experience moderate to severe pain than those who received placebo. The anatomy of the female and male urogenital tract differ. The female urethra is approximately 3cm in length while the male urethra averages 7 cm with an external and prostatic sphincter which is the location where the most discomfort is thought to occur. A randomized control trial of 144 women undergoing rigid cystoscopy and found that pain was decreased with lidocaine vs placebo, however other studies such found no difference in pain perception. The efficacy of lidocaine gel in women during flexible cystoscopy has not been studied. The use of lidocaine gel during diagnostic flexible cystoscopy in women is based on surgeon preference and experience, and use of either plain or anesthetic gel, is currently acceptable clinical practice. The morbidity and cost of local anesthesia associated with cystoscopy in women is unknown due to the lack of studies. The objective of this study is to determine if there is a clinically meaningful difference in pain perception in women during in-office diagnostic flexible cystoscopy when using lidocaine gel vs plain lubricant.

03

Conditions studied

  • Cystoscopy
  • Lidocaine
  • Pain Perception

Browse trials for

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • need for in office diagnostic flexible cystoscopy

Exclusion criteria

Exclusion Criteria:

  • urethral stricture
  • simultaneous scheduling or performed additional procedure
  • current urinary tract infection
  • to local anesthetic of amide type
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
129 participants (actual)

Study arms

  • Active comparator
    Lidocaine gel

    Drug: lidocaine gel

  • Placebo comparator
    Lubricant Gel

    Drug: Lubricant Gel

Interventions

  • 2% lidocaine jelly, injected into the urethra

  • DrugLubricant Gel

    Lubricating gel

    Also known as: Plain gel

06

What researchers measure

Primary outcomes

  1. Pain and satisfaction

    Composite of pain and satisfaction as determined by a Numeric Rating Scale for pain (validated measure) rating pain, as well as answers to yes or no questions asking if patient would repeat procedure in same method and if pain medicine is needed at end of procedure.

    Time frame: Recorded immediately after the procedure

Secondary outcomes

  1. Anticipated pain

    Composite of pain anticipated during procedure and compared to actual pain perceived as determined by a Numeric Rating Scale for pain (validated measure) rating pain

    Time frame: Recorded prior to procedure at time of enrollment into study (anticipated) and immediately after procedure

07

Study locations

1 site
  • Louisiana State University- Health Science Center
    New Orleans, Louisiana 70112, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03347721
Lead sponsor
Louisiana State University Health Sciences Center in New Orleans
Responsible party
Erin Dougher (Principal Investigator, Louisiana State University Health Sciences Center in New Orleans) — Principal investigator
First posted
Nov 20, 2017
Start date
Dec 1, 2016
Primary completion
Jun 30, 2018 (estimated)
Completion
Jun 30, 2018 (estimated)
Last update
Mar 21, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Lidocaine

Start the discussion